MoneyWorks4Me

Lyka Labs - Quaterly Results

11 Aug 2026 Evaluate
The sales moved up 45.01% to Rs. 423.09 millions for the June 2026 quarter as compared to Rs. 291.76 millions during the year-ago period.Net Profit witnessed a 158.94% growth almost the double from Rs. 8.11 millions to Rs. 21.00  millions  of same quarter last year.OP of the company witnessed a marginal growth to 50.11 millions from 41.31 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 423.09 291.76 45.01 423.09 291.76 45.01 1209.05 1346.97 -10.24
Other Income 4.19 7.73 -45.80 4.19 7.73 -45.80 39.74 27.60 43.99
PBIDT 50.11 41.31 21.30 50.11 41.31 21.30 15.66 201.72 -92.24
Interest 10.08 8.51 18.45 10.08 8.51 18.45 33.27 23.05 44.34
PBDT 40.03 32.80 22.04 40.03 32.80 22.04 -247.75 178.67 -238.66
Depreciation 20.10 21.12 -4.83 20.10 21.12 -4.83 84.60 67.66 25.04
PBT 19.93 11.68 70.63 19.93 11.68 70.63 -332.35 111.01 -399.39
TAX -1.07 3.57 -129.97 -1.07 3.57 -129.97 -9.47 31.83 -129.75
Deferred Tax -1.07 0.47 -327.66 -1.07 0.47 -327.66 -17.75 4.57 -488.40
PAT 21.00 8.11 158.94 21.00 8.11 158.94 -322.88 79.18 -507.78
Equity 361.53 361.53 0.00 361.53 361.53 0.00 356.90 356.90 0.00
PBIDTM(%) 11.84 14.16 -16.35 11.84 14.16 -16.35 1.30 14.98 -91.35

Lyka Labs Share Price

73.46 1.44 (2.00%)
21-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1900.90
Dr. Reddys Labs. 1175.00
Cipla 1426.20
Lupin 2193.00
Zydus Lifesciences 1120.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: